Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Neuroblastoma 2 Recurrence 1 Ovarian Neoplasms 1

Interventions

Vinorelbine 4 Dexamethasone 4 Filgrastim 3 Vincristine 2 Peripheral Blood Stem Cell Transplantation 2 Granulocyte Colony-Stimulating Factor 2 Gemcitabine 2 Fenretinide 2 Etoposide 2 Cytarabine 2 Carmustine 2 Bortezomib 2 zanubrutinib 1 relatlimab 1 pomalidomide 1 pegaspargase 1 palbociclib 1 liposomal amphotericin B 1 ixazomib 1 irinotecan sucrosofate 1 interferon gamma-1b 1 interferon gamma, Cys(-3), Tyr(-2), Cys(-1)- 1 imetelstat 1 etoposide phosphate 1 elotuzumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 carfilzomib 1 auricularum 1 aldesleukin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Recurrence × Ketoconazole × Clear all

NCT02163356 2022-03-31

SPOC2013-001

South Plains Oncology Consortium

Phase 1 Terminated

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡